Trademark Logo
Application Number:4252322
Status: DRAFT
Class:5
Applicant:PHARMAZZ, INC.
Filing Date:Wed, 31 Jul 2019
In Progress

Is this your trademark application?

"ZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.

Get free status guidance

+91

Trademark Information

TrademarkZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America
Trademark TypeWordmark
Class5
Application Number4252322
Nature/Scope of businesspharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.
PublicationIn Journal No. 1918
Status DRAFT
Applicant:PHARMAZZ, INC.
Applicant AddressSuite 106, 50 West 75th Street, Willowbrook, Illinois, United States, 60527 A company incorporated under the laws of United States of America
JurisdictionDELHI
AgentLUTHRA & LUTHRA LAW OFFICES
Agent Address103 ASHOKA ESTATE 24 BARAKHAMBA ROAD, NEW DELHI-1

Frequently Asked Questions

What is the status of trademark ZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America?
The trademark application number 4252322 is currently marked as "DRAFT" in the official trademark registry.
Who is the owner of trademark ZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America?
The trademark application number 4252322 is owned by PHARMAZZ, INC..
Which class does trademark ZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America belong to?
Trademark application number 4252322 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 4252322?
The trademark agent associated with application number 4252322 is LUTHRA & LUTHRA LAW OFFICES.
Was trademark ZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America published in the journal?
Yes, trademark application number 4252322 was published in Journal No. 1918.
What is trademark ZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America?
Trademark application number 4252322 relates to "pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.".

File Trademark at Just ₹1,499 + Govt Fees

Get your trademark registered with expert guidance. Limited time offer!

File Now
Expert Consultation
Quick Processing
100% Support
Free Report

Get Detailed Trademark Report

Comprehensive analysis of your trademark search delivered to your phone

+91

What you'll get:

  • Complete trademark analysis
  • Conflict assessment
  • Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified